1
|
LI F, LUO Q. [Application advances of mass spectrometry imaging technology in environmental pollutants analysis and their toxicity research]. Se Pu 2024; 42:150-158. [PMID: 38374595 PMCID: PMC10877477 DOI: 10.3724/sp.j.1123.2023.11005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2023] [Indexed: 02/21/2024] Open
Abstract
Environmental exposures have significant impacts on human health and can contribute to the occurrence and development of diseases. Pollutants can enter the body through ingestion, inhalation, dermal absorption, or mother-to-child transmission, and can metabolize and/or accumulate in different tissues and organs. These pollutants can recognize and interact with various biomolecules, including DNA, RNA, proteins, and metabolites, disrupting biological processes and leading to adverse effects in living organisms. Thus, it is crucial to analysis the exogenous pollutants in the body, identify potential biomarkers and investigate their toxic effects. Numerous studies have shown that the metabolism rate of environmental pollutants greatly differs in various tissues and organs, their accumulation is also heterogeneous and dynamically changing. Moreover, the synthesis and accumulation of endogenous metabolites exhibit precise spatial distributions in tissues and cells. Mapping the spatial distributions of both pollutants and endogenous metabolites can discover relevant exposure biomarkers and provide a better understanding of their toxic effects and molecular mechanisms. Mass spectrometry is currently the preferred method for the qualitative and quantitative analysis of various compounds, and has been extensively utilized in pollutant and metabolomics analyses. Mass spectrometry imaging (MSI) is an emerging technology for molecular imaging that combines the information obtained by mass spectrometry with the visualization of the two- and three-dimensional spatial distributions of various molecular species in thin sample sections. Unlike other molecular imaging techniques, MSI can perform the label-free and untargeted analysis of thousands of molecules, such as elements, metabolites, lipids, peptides, proteins, pollutants, and drugs, in a single experiment with high sensitivity and throughput. Different MSI technologies, such as matrix-assisted laser desorption ionization mass spectrometry imaging, secondary ion mass spectrometry imaging, desorption electrospray ionization mass spectrometry imaging, and laser ablation inductively coupled plasma mass spectrometry imaging, have been introduced for the mapping of compounds and elements in biological, medical, and clinical research. MSI technologies have recently been utilized to characterize the spatial distribution of pollutants in the whole body and specific tissues of organisms, assess the toxic effects of pollutants at the molecular level, and identify exposure biomarkers. Such developments have brought new perspectives to investigate the toxicity of environmental pollutants. In this review, we provide an overview of the principles, characteristics, mass analyzers, and workflows of different MSI techniques and introduce their latest application advances in the analysis of environmental pollutants and their toxic effects.
Collapse
|
2
|
Liang Q, Mondal P, Li Q, Maqbool T, Zhao C, Jiang D, Szulczewski GJ, Wijeratne GB. Nitro Indole Derivatives as Novel Dual-Polarity Matrices for MALDI Mass Spectrometry and Imaging with Broad Applications. Anal Chem 2024; 96:1668-1677. [PMID: 38226847 DOI: 10.1021/acs.analchem.3c04684] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2024]
Abstract
A new matrix framework is presented in this study for the improved ionization efficiency of complex mixtures by matrix-assisted laser desorption ionization (MALDI) mass spectrometry/imaging. Five nitro indole (NI) derivatives [3-methyl-4-nitro-1H-indole (3,4-MNI), 3-methyl-6-nitro-1H-indole (3,6-MNI), 2,3-dimethyl-4-nitro-1H-indole (2,3,4-DMNI), 2,3-dimethyl-6-nitro-1H-indole (2,3,6-DMNI), and 4-nitro-1H-indole (4-NI)] were synthesized and shown to produce both positive and negative ions with a broad class of analytes as MALDI matrices. NI matrices were compared to several common matrices, such as 2,5-dihydroxybenzoic acid (DHB), alpha-cyano-4-hydroxylcinnamic acid (CHCA), sinapinic acid (SA), 1,5-diaminonaphthelene (1,5-DAN), and 9-aminoacridine (9-AA), for the analysis of lipid, peptide, protein, glycan, and perfluorooctanesulfonic acid (PFOS) compounds. 3,4-MNI demonstrated the best performance among the NI matrices. This matrix resulted in reduced ion suppression and better detection sensitivity for complex mixtures, for example, egg lipids/milk proteins/PFOS in tap water, while 2,3,6-DMNI was the best matrix for blueberry tissue imaging. Several important aspects of this work are reported: (1) dual-polarity ion production with NI matrices and complex mixtures; (2) quantitative analysis of PFOS with a LOQ of 0.5 ppb in tap water and 0.05 ppb in MQ water (without solid phase extraction enrichment), with accuracy and precision within 5%; (3) MALDI imaging with 2,3,6-DMNI as a matrix for plant metabolite/lipid identification with ionization enhancement in the negative ion mode m/z 600-900 region; and (4) development of a thin film deposition under/above tissue method for MALDI imaging with a vacuum sublimation matrix on a high-vacuum MALDI instrument.
Collapse
Affiliation(s)
- Qiaoli Liang
- Department of Chemistry & Biochemistry, The University of Alabama, Tuscaloosa, Alabama 35487, United States
| | - Pritam Mondal
- Department of Chemical Sciences, Indian Institute of Science Education and Research Mohali, Punjab 140306, India
| | - Qi Li
- Department of Chemical and Biological Engineering, The University of Alabama, Tuscaloosa, Alabama 35487, United States
| | - Tahir Maqbool
- Department of Civil, Construction and Environmental Engineering, The University of Alabama, Tuscaloosa, Alabama 35487, United States
| | - Chao Zhao
- Department of Chemical and Biological Engineering, The University of Alabama, Tuscaloosa, Alabama 35487, United States
| | - Daqian Jiang
- Department of Civil, Construction and Environmental Engineering, The University of Alabama, Tuscaloosa, Alabama 35487, United States
| | - Greg J Szulczewski
- Department of Chemistry & Biochemistry, The University of Alabama, Tuscaloosa, Alabama 35487, United States
| | - Gayan B Wijeratne
- Department of Chemistry & Biochemistry, The University of Alabama, Tuscaloosa, Alabama 35487, United States
| |
Collapse
|
3
|
Rajbhandari P, Neelakantan TV, Hosny N, Stockwell BR. Spatial pharmacology using mass spectrometry imaging. Trends Pharmacol Sci 2024; 45:67-80. [PMID: 38103980 PMCID: PMC10842749 DOI: 10.1016/j.tips.2023.11.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2023] [Revised: 11/07/2023] [Accepted: 11/11/2023] [Indexed: 12/19/2023]
Abstract
The emerging and powerful field of spatial pharmacology can map the spatial distribution of drugs and their metabolites, as well as their effects on endogenous biomolecules including metabolites, lipids, proteins, peptides, and glycans, without the need for labeling. This is enabled by mass spectrometry imaging (MSI) that provides previously inaccessible information in diverse phases of drug discovery and development. We provide a perspective on how MSI technologies and computational tools can be implemented to reveal quantitative spatial drug pharmacokinetics and toxicology, tissue subtyping, and associated biomarkers. We also highlight the emerging potential of comprehensive spatial pharmacology through integration of multimodal MSI data with other spatial technologies. Finally, we describe how to overcome challenges including improving reproducibility and compound annotation to generate robust conclusions that will improve drug discovery and development processes.
Collapse
Affiliation(s)
- Presha Rajbhandari
- Department of Biological Sciences, Columbia University, New York, NY, USA
| | | | - Noreen Hosny
- Irving Institute for Cancer Dynamics, Columbia University, New York, NY, USA; Department of Molecular Biology, Princeton University, Princeton, NJ, USA
| | - Brent R Stockwell
- Department of Biological Sciences, Columbia University, New York, NY, USA; Department of Chemistry, Columbia University, New York, NY, USA; Irving Institute for Cancer Dynamics, Columbia University, New York, NY, USA; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA; Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
| |
Collapse
|
4
|
Fresnais M, Liang S, Seven D, Prodanovic N, Sundheimer J, Haefeli WE, Burhenne J, Longuespée R. Desorption Kinetics Evaluation for the Development of Validated Desorption Electrospray Ionization-Mass Spectrometric Assays for Drug Quantification in Tissue Sections. Int J Mol Sci 2023; 24:ijms24108469. [PMID: 37239813 DOI: 10.3390/ijms24108469] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2023] [Revised: 04/24/2023] [Accepted: 05/05/2023] [Indexed: 05/28/2023] Open
Abstract
The development of desorption/ionization (DI) mass spectrometric (MS) assays for drug quantification in tissue sections and their validation according to regulatory guidelines would enable their universalization for applications in (clinical) pharmacology. Recently, new enhancements in desorption electrospray ionization (DESI) have highlighted the reliability of this ion source for the development of targeted quantification methods that meet requirements for method validation. However, it is necessary to consider subtle parameters leading to the success of such method developments, such as the morphology of desorption spots, the analytical time, and sample surface, to cite but a few. Here, we provide additional experimental data highlighting an additional important parameter, based on the unique advantage of DESI-MS on continuous extraction during analysis. We demonstrate that considering desorption kinetics during DESI analyses would largely help (i) reducing analytical time during profiling analyses, (ii) verifying solvent-based drug extraction using the selected sample preparation method for profiling and imaging modes, and (iii) predicting the feasibility of imaging assays using samples in a given expected concentration range of the targeted drug. These observations will likely serve as precious guidance for the development of validated DESI-profiling and imaging methods in the future.
Collapse
Affiliation(s)
- Margaux Fresnais
- Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany
| | - Siwen Liang
- Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany
| | - Deniz Seven
- Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany
| | - Nevena Prodanovic
- Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany
| | - Julia Sundheimer
- Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 430, 69120 Heidelberg, Germany
- Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
- Faculty of Biosciences, Heidelberg University, Im Neuenheimer Feld 234, 69120 Heidelberg, Germany
| | - Walter E Haefeli
- Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany
| | - Jürgen Burhenne
- Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany
| | - Rémi Longuespée
- Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany
| |
Collapse
|
5
|
Proteomics as a New-Generation Tool for Studying Moulds Related to Food Safety and Quality. Int J Mol Sci 2023; 24:ijms24054709. [PMID: 36902140 PMCID: PMC10003330 DOI: 10.3390/ijms24054709] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2023] [Revised: 02/24/2023] [Accepted: 02/26/2023] [Indexed: 03/06/2023] Open
Abstract
Mould development in foodstuffs is linked to both spoilage and the production of mycotoxins, provoking food quality and food safety concerns, respectively. The high-throughput technology proteomics applied to foodborne moulds is of great interest to address such issues. This review presents proteomics approaches useful for boosting strategies to minimise the mould spoilage and the hazard related to mycotoxins in food. Metaproteomics seems to be the most effective method for mould identification despite the current problems related to the bioinformatics tool. More interestingly, different high resolution mass spectrometry tools are suitable for evaluating the proteome of foodborne moulds able to unveil the mould's response under certain environmental conditions and the presence of biocontrol agents or antifungals, being sometimes combined with a method with limited ability to separate proteins, the two-dimensional gel electrophoresis. However, the matrix complexity, the high ranges of protein concentrations needed and the performing of multiple steps are some of the proteomics limitations for the application to foodborne moulds. To overcome some of these limitations, model systems have been developed and proteomics applied to other scientific fields, such as library-free data independent acquisition analyses, the implementation of ion mobility, and the evaluation of post-translational modifications, are expected to be gradually implemented in this field for avoiding undesirable moulds in foodstuffs.
Collapse
|